Cyclarity’s one-page company profile now available for download and review.

Cyclarity Therapeutics, Inc.  is proud to present a one-sheet summarizing our approach to curing heart disease, the results we’ve achieved thus far, and the status of our ongoing efforts.

About Cyclarity Therapeutics, Inc.

Cyclarity Therapeutics, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting oxidized cholesterol using rationally designed molecules, to provide the first true disease-modifying treatments for common age-related conditions such as atherosclerosis, heart attack and stroke. Its products are based on novel derivatives of a well-known, safe compound and a new way of looking at cardiovascular disease. For more information, please visit or send an email to


Mike Kope
CEO of Corporate Affairs
Cyclarity Therapeutics, Inc.